You have 9 free searches left this month | for more free features.

jnj-63723283

Showing 1 - 3 of 3

STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS

Tumor Trial in Chuo-Ku, Kashiwa (JNJ-63723283, Erdafitinib)

Completed
  • Neoplasm
  • Chuo-Ku, Japan
  • +1 more
Nov 3, 2022

Multiple Myeloma Trial in Belgium, Israel, Spain (Daratumumab, JNJ-63723283)

Completed
  • Multiple Myeloma
  • Antwerpen, Belgium
  • +12 more
Dec 1, 2022

Tumors Trial in Worldwide (JNJ-63723283)

Recruiting
  • Neoplasms
  • JNJ-63723283
  • Saint Louis, Missouri
  • +32 more
Aug 11, 2022